» Articles » PMID: 2829955

Phase I/II Study of Recombinant Human Granulocyte Colony-stimulating Factor in Patients Receiving Intensive Chemotherapy for Small Cell Lung Cancer

Overview
Journal Br J Cancer
Specialty Oncology
Date 1987 Dec 1
PMID 2829955
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Twelve patients with advanced small cell carcinoma of the bronchus were treated by continuous infusion of recombinant human granulocyte colony-stimulating factor (rhG-CSF) at the following dose levels: 1 microgram, 5 micrograms, 10 micrograms, 20 micrograms and 40 micrograms kg-1 day-1 for 5 days. No toxicities resulted from the treatment and in all 12 patients the number of peripheral neutrophils increased rapidly to a maximum of 100 x 10(9) l-1 at 10 micrograms kg-1 day-1. The neutrophils were shown to be functionally normal in tests of their mobility and bactericidal activity. During the phase II part of the study the patients were treated by a combination of intravenous adriamycin 50 mg m-2, ifosfamide 5 g m-2 by i.v. infusion with mesna 8 g m-2 on day 1, and etoposide 120 mg m-2 on days 1, 2 and 3 also intravenously. The chemotherapy regime was repeated every 3 weeks. RhG-CSF was given to each patient for 14 days on alternate cycles of chemotherapy and reduced the period of absolute neutropenia considerably (median of 80%), with a return to normal, or above normal, neutrophil counts within 2 weeks after day 1 of chemotherapy. Six severe infective episodes were observed during the cycles of chemotherapy which did not include rhG-CSF, while no infective episodes occurred when patients were treated with rhG-CSF. These results demonstrate the utility of rhG-CSF in restoring functional neutrophils to patients undergoing intensive chemotherapy.

Citing Articles

Neutrophil diversity and function in health and disease.

Zhang F, Xia Y, Su J, Quan F, Zhou H, Li Q Signal Transduct Target Ther. 2024; 9(1):343.

PMID: 39638788 PMC: 11627463. DOI: 10.1038/s41392-024-02049-y.


Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis.

Malengier-Devlies B, Metzemaekers M, Wouters C, Proost P, Matthys P Front Immunol. 2021; 12:766620.

PMID: 34966386 PMC: 8710701. DOI: 10.3389/fimmu.2021.766620.


Cobalt protoporphyrin IX increases endogenous G-CSF and mobilizes HSC and granulocytes to the blood.

Szade A, Szade K, Nowak W, Bukowska-Strakova K, Muchova L, Gonka M EMBO Mol Med. 2019; 11(12):e09571.

PMID: 31709729 PMC: 6895613. DOI: 10.15252/emmm.201809571.


Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche.

de Kruijf E, Fibbe W, van Pel M Ann N Y Acad Sci. 2019; 1466(1):24-38.

PMID: 31006885 PMC: 7217176. DOI: 10.1111/nyas.14059.


Optimization of Extended-Release ZL-004 Nanosuspensions for In Vivo Pharmacokinetic Study to Enhance Low Solubility and Compliance.

Guo C, Chen Y, Zhu J, Wang J, Xu Y, Luan H Molecules. 2018; 24(1).

PMID: 30577480 PMC: 6337511. DOI: 10.3390/molecules24010007.


References
1.
Bodey G, Buckley M, SATHE Y, Freireich E . Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966; 64(2):328-40. DOI: 10.7326/0003-4819-64-2-328. View

2.
Winston D, Ho W, Gale R . Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med. 1982; 97(4):509-15. DOI: 10.7326/0003-4819-97-4-509. View

3.
Young L . The role of granulocyte transfusions in treating and preventing infection. Cancer Treat Rep. 1983; 67(2):109-11. View

4.
Groopman J, Mitsuyasu R, DeLeo M, Oette D, Golde D . Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med. 1987; 317(10):593-8. DOI: 10.1056/NEJM198709033171003. View

5.
Cerny T, Blair V, Anderson H, Bramwell V, Thatcher N . Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer. 1987; 39(2):146-9. DOI: 10.1002/ijc.2910390204. View